drugset / Trial / NCT00520338

Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial

NCT00520338

Phase 4 Completed 80 enrolled Mahidol University
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether celecoxib is effective in the treatment postoperative pain after thyroidectomy. The research hypothesis: There is a difference in postoperative morphine consumption in the first 24 hours after thyroidectomy between patients who received celecoxib or placebo.

Timeline

Start
2007-08
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 400 mg Oral

Indications

No indication recorded.